2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections   Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes   Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease 8 s* z( u* L" X. V8 D; N  Press Release
20.	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers   Press Release
19.	Kerydin      E! F0 y% p. J  p  N/ x2 j: e3 k	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails ! ^  I# P, V# O" W' ]+ q7 t9 |  (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL)   Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections " {) ?' l5 G0 R  Press Release
16.	Jublia    . u" J% T! b1 m$ e: G! C; Y7 K$ ]  p	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection)    No Press Release
15.	Dalvance 9 {/ H* r. Q* C( y) [   0 Q/ a2 l  l* \" u	dalbavancin	5/23/2014	To treat adults with skin  infections   Press Release
14.	Entyvio	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease   Press Release
13.	Zontivity 4 _( ?2 X* z$ Z6 t! i	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients ' v# H9 ?. E# s" M8 e, ?+ i, e  Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) 0 p, e& f% p0 `: E* u( x* k% w  Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes) : r" g9 c8 ^( \1 Z. {. i, S" b  Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma . F$ H" O0 B! b) C  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA)   Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis   Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency ! R, |: K8 o7 m- G. |! @! \- \  Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH) ( p0 M7 O8 B7 A* }) E' _( s8 y6 ?. {  Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome) , Q/ ]# V7 h) O4 x- p9 U1 A9 e  Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release

! J% d7 b, J7 D7 m& h

& ]& X2 A- v" o5 q: @$ s2 ~

感谢楼主分享，楼主好强大